Device of Tomorrow Capital — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.
BiotechDeep TechHealthtechMedical DevicesSomerville, US
MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)inNicolette Driscoll(Founder)in
Co-investorsDolby Family VenturesEmpath VenturesFuture VenturesGreyMatterMana VenturesPioneer+4 more
Vonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull.
Deep TechHealthtechMedical Devices
José Morales(Dr.)
Co-investorsXEIA Venture PartnersSmartGateVC
Wearlinq develops the eWave, a wireless, FDA-cleared 6-lead continuous ECG cardiac monitor with a patient smartphone app and the LiveLinq platform for clinicians to review ECG waveforms and reports.
Digital HealthHardwareMedical DevicesSan Francisco, US
Michael Torres(Executive Officer)inChris Daniel(Executive Officer)inYuxin Liu(Executive Officer, Director)Konrad Morzkowski(Executive Officer, Director)
BoardKrish W. Ramadurai(Director)inJoseph Knight(Director)
Co-investorsAIX VenturesAju IB InvestmentAlumni VenturesAmino CapitalCeltic House Asia PartnersHealthtech Capital+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












-2.png)